Personalized multifactorial risk assessment in neoadjuvant-treated breast carcinoma
The results emphasize the value of comprehensive evaluation of conventional patient and biomarker characteristics, especially concerning re-assessment of biomarkers, risk-adapted surveillance, and personalized treatment strategies. Future personalized NA-treatment strategies might benefit from models combining risk-adapted surveillance data and post-NAT re-assessed biomarkers.
Authors
- Kati Talvinen (ORCID: https://orcid.org/0000-0001-6002-5347)
- E. Löyttyniemi
- Pauliina Kronqvist (ORCID: https://orcid.org/0000-0001-8922-0648)
- K. Korpinen (ORCID: https://orcid.org/0000-0003-4833-2613)
- Tuomo-Artturi Autere
- Jukka Tuominen
- Natalja Eigėlienė
Institutions
- University of Turku (FI)
- Turku University Hospital (FI)
- Vaasa Central Hospital (FI)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1007/s10549-024-07584-4
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Suomen Lääketieteen Säätiö
- Minerva Foundation
- Turun Yliopisto
- Vaasan Keskussairaala
- Turun Yliopistollinen Keskussairaala